Product ID | 43386-050_3ff4d772-6527-4791-9236-e1a97878a200 |
NDC | 43386-050 |
Product Type | Human Prescription Drug |
Proprietary Name | GaviLyte - N |
Generic Name | Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate |
Dosage Form | Powder, For Solution |
Route of Administration | ORAL |
Marketing Start Date | 2009-05-28 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA090019 |
Labeler Name | Lupin Pharmaceuticals,Inc. |
Substance Name | POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE |
Active Ingredient Strength | 420 g/438.4g; g/438.4g; g/438.4g; g/438.4g |
Pharm Classes | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |